Condition: Bipolar I Disorder · Depression, Anxiety · Stress · Sponsor: Mclean Hospital
This is a randomized, double-blind, placebo-controlled proof-of-concept clinical trial to assess the efficacy and safety of Magnesium-vitamin B6in combination with treatment as usual for treating symptoms of depression, stress, and anxiety in patients with first episode bipolar I disorder.
This description comes directly from the study's public registry record.
Kyle Cuklanz, B.S. · 617-855-2637 · kcuklanz@mclean.harvard.edu
Virginie-Anne Chouinard, M.D. · 617-855-3034 · vchouinard@mclean.harvard.edu
Always discuss trial participation with your own doctor first.
| McLean Hospital | Belmont, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05837104